CYP1A2 and cancer: For instance, CYPs (e.g., CYP1A2) catalyze 2-hydroxylation of estradiol in which the product (i.e., 2-methoxyestradiol) inhibits cancer cell proliferation [47,48], suggesting reduced CYP1A2 activity due to PhIP exposure may trigger carcinogenesis.